结直肠癌中的KRAS和MT-CO1基因:一个分子调查
Harmand A Hama1, Bestoon S Hasan2, Basak Barzngy3
1Department of Biology, Faculty of Education, Tishk International University, Erbil, Kurdistan Region of Iraq. harmand.ali@tiu.edu.iq.
Cellular and molecular biology (Noisy-le-Grand, France)
|November 28, 2023
概括
这项研究在结直肠癌 (CRC) 组织中发现KRAS瘤基因表达升高,而MT-CO1瘤抑制基因表达没有显著差异. 在CRC中观察到MT-CO1和KRAS之间存在负相关性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症死亡的主要原因.
- 瘤抑制基因MT-CO1和瘤基因KRAS在细胞调节中起着至关重要的作用.
- MT-CO1和KRAS的失调与癌症的发展有关.
研究的目的:
- 在结直肠癌 (CRC) 活检样本中研究KRAS和MT-CO1的表达水平.
- 探索CRC患者中KRAS和MT-CO1表达之间的关系.
- 评估这些基因作为CRC检测和预后生物标志物的潜力.
主要方法:
- 分析了42个结直肠癌组织样本和相应的对照.
- 使用逆转录酶-聚合酶链反应 (RT-PCR) 评估KRAS和MT-CO1基因表达.
- 统计分析包括千平方和相关性测试 (p<0.05).
主要成果:
- 与对照组相比,CRC组织中的KRAS表达显著上调 (p=0.0001).
- 在CRC组织和对照组织之间,MT-CO1表达没有显著差异 (p=0.12).
- 在CRC组织中MT-CO1和KRAS表达之间发现了显著的负相关性 (p=0.0001,r=-0.047).
结论:
- KRAS和MT-CO1表达的变化及其相关性可以作为CRC检测和预后的指标.
- 需要进一步的研究来阐明CRC中这些基因相互作用的潜在机制.
- 这些发现可能有助于促进结直肠癌转化研究的进步.
更多相关视频
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
5.5K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.8K
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
